Butterfly Network (BFLY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Voting matters and shareholder proposals
Seven directors are nominated for election to serve one-year terms expiring in 2027.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 is proposed.
Advisory vote on executive compensation for named executive officers is included.
Proxies may vote on other business that may arise during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all seven director nominees for election.
Nominees include Joseph DeVivo, Jonathan M. Rothberg, Larry Robbins, Caroll H. Neubauer, Elazer Edelman, S. Louise Phanstiel, and Erica Schwartz.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers as disclosed in the proxy statement.
Latest events from Butterfly Network
- Q1 2026 revenue up 25%, gross margin at 68.9%, and adjusted EBITDA loss narrowed to $6.1M.BFLY
Q1 202630 Apr 2026 - Proxy covers director elections, auditor ratification, and executive pay, with founder holding voting control.BFLY
Proxy filing27 Apr 2026 - AI-powered ultrasound and embedded tech drive growth, with 2026 revenue seen at $117M-$121M.BFLY
TD Cowen 46th Annual Health Care Conference25 Apr 2026 - AI-driven chip innovation, global expansion, and new partnerships fuel strong growth and revenue.BFLY
44th Annual J.P. Morgan Healthcare Conference16 Apr 2026 - Record Q4 revenue, margin gains, and positive cash flow set stage for 2026 growth.BFLY
Q4 20258 Apr 2026 - Record Q2 revenue, narrowed losses, and improved guidance reflect strong growth and efficiency.BFLY
Q2 20242 Feb 2026 - Revolutionizing ultrasound with digital, AI-enabled devices and strategic licensing for growth.BFLY
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Q3 revenue up 33%, net loss narrowed, and guidance raised amid global and AI expansion.BFLY
Q3 202417 Jan 2026 - Handheld ultrasound innovation, AI, and global expansion drive strong growth and future disruption.BFLY
2024 CG MedTech, Diagnostics and Digital Health & Services Forum13 Jan 2026